NCT01689636View on ClinicalTrials.gov

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

July 31, 2002

Conditions
Ovarian CancerHealthy Volunteers
Interventions
DRUG

Tc 99m EC20

Trial Locations (1)

Unknown

Washington University Medical Center, St Louis

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01689636 - Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter